Overview
Morphine, the main alkaloid of opium, was first obtained from poppy seeds in 1805. It is a potent analgesic, though its use is limited due to tolerance, withdrawal, and the risk of abuse. Morphine is still routinely used today, though there are a number of semi-synthetic opioids of varying strength such as codeine, fentanyl, methadone, hydrocodone, hydromorphone, meperidine, and oxycodone. Morphine was granted FDA approval in 1941.
Background
Morphine, the main alkaloid of opium, was first obtained from poppy seeds in 1805. It is a potent analgesic, though its use is limited due to tolerance, withdrawal, and the risk of abuse. Morphine is still routinely used today, though there are a number of semi-synthetic opioids of varying strength such as codeine, fentanyl, methadone, hydrocodone, hydromorphone, meperidine, and oxycodone. Morphine was granted FDA approval in 1941.
Indication
Morphine is used for the management of chronic, moderate to severe pain. Opiods, including morphine, are effective for the short term management of pain. Patients taking opioids long term may need to be monitored for the development of physical dependence, addiction disorder, and drug abuse.
Associated Conditions
- Chronic Pain
- Severe Pain
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2019/03/22 | Not Applicable | UNKNOWN | Medical University of Warsaw | ||
2019/03/14 | Not Applicable | Completed | Medical University of Warsaw | ||
2019/02/19 | Phase 4 | Terminated | Zuyderland Medisch Centrum | ||
2019/02/18 | Phase 4 | Completed | Bruno Minotti | ||
2019/02/15 | Not Applicable | Completed | Shanghai Zhongshan Hospital | ||
2019/02/07 | Phase 4 | Completed | Huib A.M. Kerstjens | ||
2019/01/31 | Phase 3 | Completed | Children's Cancer Hospital Egypt 57357 | ||
2019/01/31 | Phase 3 | UNKNOWN | Dr M. B. Breebaart | ||
2019/01/30 | Phase 3 | Recruiting | |||
2019/01/18 | Phase 4 | Completed |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Rhodes Pharmaceuticals L. P. | 42858-805 | ORAL | 200 mg in 1 1 | 12/31/2023 | |
| Par Pharmaceutical Inc. | 49884-666 | ORAL | 30 mg in 1 1 | 2/19/2015 | |
| Hi-Tech Pharmacal Co., Inc. | 50383-855 | ORAL | 2 mg in 5 mL | 4/13/2016 | |
| Hospira, Inc. | 0409-3814 | EPIDURAL, INTRATHECAL, INTRAVENOUS | 0.5 mg in 1 mL | 3/1/2024 | |
| STAT RX USA LLC | 16590-593 | ORAL | 60 mg in 1 1 | 9/22/2011 | |
| Hospira, Inc. | 0409-1894 | INTRAVENOUS | 15 mg in 1 mL | 3/30/2023 | |
| Lake Erie Medical DBA Quality Care Products LLC | 55700-366 | ORAL | 15 mg in 1 1 | 10/29/2019 | |
| Actavis Pharma, Inc. | 0228-4323 | ORAL | 100 mg in 1 1 | 8/14/2021 | |
| Purdue Pharma LP | 59011-264 | ORAL | 200 mg in 1 1 | 3/23/2017 | |
| Lake Erie Medical DBA Quality Care Products LLC | 55700-368 | ORAL | 60 mg in 1 1 | 10/29/2019 |
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||